Expression of stromelysin and urokinase type plasminogen activator protein in resection specimens and biopsies at different stages of osteoarthritis of the knee

Pathology Research and Practice

Volumn 196, Issue 4, 2000, Pages 219-226

  Pap, Géza ^a,b   Eberhardt, René ^a   Rocken C ^a   Nebelung, W ^a   Neumann, H W ^a   Roessner, A ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b Orthopädische Univ Klin   (Germany)

Author keywords

Biopsy; Knee; Mankin score; MMP 3; Osteoarthritis; u PA

Indexed keywords

STROMELYSIN; UROKINASE;

ARTICLE; BIOPSY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; EXCISION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

EID: 0034042204     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0344-0338(00)80070-9     Document Type: Article

References (54)

1. Adams ME (1992) Cartilage research and treatment of osteoarthritis. Curr Opin Rheumatol 4: 552-559
2. Aigner T, Dietz U, Stoss H, von der M (1995) Differential expression of collagen types I, II, III, and X in human osteophytes. Lab Invest 73: 236-243
3. Aigner T, Reichenberger E, Bertling W, Kirsch T, Stoss H, von der M (1993) Type X collagen expression in osteoarthritic and rheumatoid articular cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol 63: 205-211
4. Aigner T, Stöß H, Weseloh G, Zeiler G, von der Mark K (1992) Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol 62: 337-345
5. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M (1986) Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29: 1039-1049
6. Altman RD (1997) The syndrome of osteoarthritis. J Rheumatol 24: 766-767
7. Baici A, Horler D, Lang A, Merlin C, Kissling R (1995) Cathepsin B in osteoarthritis: zonal variation of enzyme activity in human femoral head cartilage. Ann Rheum Dis 54: 281-288
8. Borella L, Eng CP, DiJoseph J, Wells C, Ward J, Caccese R, Baeder WL (1991) Rapid induction of early osteoarthritic-like lesions in the rabbit knee by continuous intra-articular infusion of mammalian collagenase or interleukin-1. Agents Actions 34: 220-222
9. Carlson CS, Loeser RF, Jayo MJ, Weaver DS, Adams MR, Jerome CP (1994) Osteoarthritis in cynomolgus macaques: a primate model of naturally occurring disease. J Orthop Res 12: 331-339
10. Chambers MG, Bayliss MT, Mason RM (1997) Chondrocyte cytokine and growth factor expression in murine osteoarthritis. Osteoarthritis.Cartilage 5: 301-308
11. Dean DD (1991) Proteinase-mediated cartilage degradation in osteoarthritis. Semin.Arthritis Rheum 20: 2-11
12. Dean DD, Martel-Pelletier J, Pelletier JP, Howell DS, Woessner JFJ (1989) Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84: 678-685
13. Dijkgraaf LC, de Bont LG, Boering G, Liem RS (1995) The structure, biochemistry, and metabolism of osteoarthritic cartilage: a review of the literature. J Oral Maxillofac Surg 53: 1182-1192
14. Felson DT (1990) The epidemiology of knee osteoarthritis: results from the Framingham Osteoarthritis Study. Semin.Arthritis Rheum 20: 42-50
15. Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland JA (1997) Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 56: 542-549
16. Gotoh H, Yamada H, Yoshihara Y, Kikuchi T, Obata K, Shinmei M (1997) Levels of matrix metalloproteinase-3 and urokinase-type plasminogen activator in knee synovial fluids from patients with rheumatoid arthritis and osteoarthritis. Ryumachi 37: 3-8
17. Hamerman D (1989) The biology of osteoarthritis. N Engl J Med 320: 1322-1330
18. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL (1995) Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis. Ann Rheum Dis 54: 25-32
19. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR (1995) Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 96: 2859-2869
20. Imai K, Ohuchi E, Aoki T, Nomura H, Fujii Y, Sato H, Seiki M, Okada Y (1996) Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinases 2. Cancer Res 56: 2707-2710
21. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T (1990) Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. An application for rheumatoid arthritis serum and plasma. J Immunol Methods 127: 103-108
22. Kolarz G, Adlassnig KP (1995) [Clinical aspects of arthrosis]. Wien Med Wochenschr 145: 101-106
23. Lapadula G, Iannone F, Zuccaro C, Covelli M, Patella V, Lobianco G, Pipitone V (1995) Expression of membrane-bound peptidases (CD10 and CD26) on human articular chondrocytes. Possible role of neuropeptidases in the pathogenesis of osteoarthritis. Clin Exp Rheumatol 13: 143-148
24. Malemud CJ (1991) Changes in proteoglycans in osteoarthritis: biochemistry, ultrastructure and biosynthetic processing. J Rheumatol Suppl 27: 60-62
25. Mankin HJ, Dorfman H, Lippiello L, Zarins A (1971) Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg [Am] 53: 523-537
26. Martel-Pelletier J, Cloutier JM, Pelletier JP (1990) Cathepsin B and cysteine protease inhibitors in human osteoarthritis. J Orthop Res 8: 336-344
27. Martel-Pelletier J, Faure MP, McCollum R, Mineau F, Cloutier JM, Pelletier JP (1991) Plasmin, plasminogen activators and inhibitor in human osteoarthritic cartilage. J Rheumatol 18: 1863-1871
28. Martel-Pelletier J, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP (1994) Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 70: 807-815
29. McAlindon TE, Wilson PW, Aliabadi P, Weissman B, Pelson DT (1999) Level of physical activity and the risk of radiographic and symptomatic knee osteoarthritis in the elderly: the Framingham study. Am J Med 106: 151-157.
30. Mohamed-Ali H (1991) Proteolytic enzymes and the destruction of articular cartilage in arthritis and chronic polyarthritis. Wien Med Wochenschr 141: 77-85
31. Muir H (1995) The chondrocyte, architect of cartilage. Biomechanics, structure, function and molecular biology of cartilage matrix macromolecules. Bioessays 17: 1039-1048
32. Nerlich AG, Wiest I, von der M (1993) Immunohistochemical analysis of interstitial collagens in cartilage of different stages of osteoarthrosis. Virchows Arch B Cell Pathol Incl Mol Pathol 63: 249-255
33. Nguyen Q, Mort JS, Roughley PJ (1992) Preferential mRNA expression of prostromelysin relative to procollagenase and in situ localization in human articular cartilage. J Clin Invest 89: 1189-1197
34. O'Byrne EM, Paul PK, Roberts ED, Blancuzzi V, Wilson D, Goldberg RL, DiPasquale G (1993) Comparison of magnetic resonance imaging (MRI) and histopathology in rabbit models of osteoarthritis and immune arthritis. Agents Actions 39 Spec No: C157-C159
35. Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, Shinmei M, Hayakawa T (1992) A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim.Acta 211: 59-72
36. Ohashi K, Kawai R, Hara M, Okada Y, Tachibana S, Ogura Y (1996) Increased matrix metalloproteinase as possible cause of osseoarticular tissue destriction in long-term haemodialysis and b2-mikroglobulin amyloidosis. Virchows Arch 428: 37-46
37. Okada Y, Konomi H, Yada T, Kimata K, Nagase H (1989) Degradation of type IX collagen by matrix metalloproteinase 3 (stromelysin) from human rheumatoid synovial cells. FEBS Lett 244: 473-476
38. Okada Y, Shinmei M, Tanaka O, Naka K, Kimura A, Nakanishi I, Bayliss MT, Iwata K, Nagase H (1992) Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium. Lab.Invest 66: 680-690
39. Pap G, Eberhardt R, Machner A, Stürmer I, Schwarzberg H, Roessner A, Neumann HW (1998) Development of Osteoarthritis in the Knee Joints of Wistar Rats After Strenuous Running Exercise in a Running Wheel by Intracranial Self-Stimulation. Pathol.Res.Pract. 194: 41-47
40. Pelletier JP, Faure MP, DiBattista JA, Wilhelm S, Visco D, Martel-Pelletier J (1993) Coordinate synthesis of stromelysin, interleukin-1, and oncogene proteins in experimental osteoarthritis. An immunohistochemical study. Am J Pathol 142: 95-105
41. Pelletier JP, Mineau F, Faure MP, Martel-Pelletier J (1990) Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritis. Arthritis Rheum 33: 1466-1476
42. Poole AR, Rizkalla G, Ionescu M, Reiner A, Brooks E, Rorabeck C, Bourne R, Bogoch E (1993) Osteoarthritis in the human knee: a dynamic process of cartilage matrix degradation, synthesis and reorganization. Agents Actions Suppl 39: 3-13
43. Rizkalla G, Reiner A, Bogoch E, Poole AR (1992) Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis. Evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 90: 2268-2277
44. Serni U, Fibbi G, Anichini E, Zamperini A, Pucci M, Mannoni A, Matucci A, Benucci M, Del Rosso A, Del Rosso M (1995) Plasminogen activator and receptor in osteoarthritis. J Rheumatol Suppl 43: 120-122
45. Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA (1997) Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 40: 2065-2074
46. Stanescu R, Knyszynski A, Muriel MP, Stanescu V (1993) Early lesions of the articular surface in a strain of mice with very high incidence of spontaneous osteoarthritic-like lesions. J Rheumatol 20: 102-110
47. Testa V, Capasso G, Maffulli M, Sgambato A, Ames PR (1994) Proteases and antiproteases in cartilage homeostasis. A brief review. Clin Orthop 308: 79-84
48. van der Sluijs JA, Geesink RG, van der Linden AJ, Bulstra SK, Kuyer R, Drukker J (1992) The reliability of the Mankin score for osteoarthritis. J Orthop Res 10: 58-61
49. von der M, Frischholz S, Aigner T, Beier F, Belke J, Erdmann S, Burkhardt H (1995) Upregulation of type X collagen expression in osteoarthritic cartilage. Acta Orthop Scand.Suppl 266: 125-129
50. von der M, Gluckert K (1990) Biochemical and molecular biologic aspects of early detection of human arthroses. Orthopade. 19: 2-15
51. von der M, Kirsch T, Nerlich A, Kuss A, Weseloh G, Gluckert K, Stoss H (1992) Type X collagen synthesis in human osteoarthritic cartilage. Indication of chondrocyte hypertrophy. Arthritis Rheum 35: 806-811
52. Walter H, Kawashima A, Nebelung W, Neumann W, Roessner A (1998) Immunohistochemical analysis of several proteolytic enzymes as parameters of cartilage degradation. Pathol Res Pract 194: 73-81
53. Wojta J, Kirchheimer JC, Turcu L, Christ G, Binder BR (1986) Monoclonal antibodies against human high molecular weight urinary urokinase: application for affinity purification of urinary pro-urokinase. Thromb Haemost 55: 347-351
54. Wu JJ, Lark MW, Chun LE, Eyre DR (1991) Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem 266: 5625-5628